```html

Resistance to Infection

What is Resistance to Infection?

“Resistance to infection” is not a disease itself; it describes the body’s ability—or lack thereof—to defend against invading microorganisms such as bacteria, viruses, fungi, and parasites. When resistance is low, a person is said to have immunodeficiency or an impaired immune response, which makes even routine exposures more likely to cause illness.

The immune system works through two major arms: innate immunity (the rapid, non‑specific defenses like skin, mucus, and phagocytic cells) and adaptive immunity (the slower, highly specific response involving B‑cells and T‑cells). Defects in either arm can lower resistance, leading to recurrent, severe, or unusual infections.

Understanding why resistance is compromised helps clinicians target the underlying cause and guide appropriate treatment or preventive measures. The information below summarizes the most common causes, associated symptoms, diagnostic steps, and management strategies.

Common Causes

Impaired resistance to infection can be congenital (present at birth) or acquired later in life. The most frequent culprits include:

• Primary immunodeficiency disorders (PIDDs) – e.g., Common Variable Immunodeficiency (CVID), Severe Combined Immunodeficiency (SCID), and X‑linked Agammaglobulinemia.
• Human Immunodeficiency Virus (HIV) infection – progressive loss of CD4⁺ T‑cells.
• Chemotherapy or radiation therapy – damage to bone marrow and lymphoid tissue.
• Immunosuppressive medications – corticosteroids, biologics (e.g., TNF‑α inhibitors), and transplant‑related drugs.
• Chronic diseases – diabetes mellitus, chronic kidney disease, and liver cirrhosis.
• Malnutrition – especially protein‑calorie deficiency, zinc, selenium, or vitamin A/D deficiencies.
• Splenectomy or functional asplenia – loss of the spleen’s filtration and antibody production functions.
• Genetic syndromes – such as DiGeorge syndrome, Wiskott‑Aldrich syndrome, or Hyper‑IgM syndrome.
• Age‑related decline – the immune system naturally weakens in very young infants and in adults older than 65 years.
• Environmental exposures – prolonged use of broad‑spectrum antibiotics leading to dysbiosis, or occupational hazards (e.g., silica dust) that impair lung immunity.

Associated Symptoms

When resistance is compromised, infections tend to follow certain patterns. Common accompanying signs include:

• Frequent respiratory infections (sinusitis, bronchitis, pneumonia).
• Recurrent or persistent skin infections (cellulitis, impetigo, fungal infections).
• Unusual infections with opportunistic organisms (e.g., Pneumocystis jirovecii, Candida, Cryptococcus, or Mycobacterium avium complex).
• Gastrointestinal symptoms such as chronic diarrhea or unexplained weight loss.
• Persistent fever of unknown origin (FUO) lasting >38 °C for more than 3 weeks.
• Swollen or enlarged lymph nodes (lymphadenopathy) and/or an enlarged spleen (splenomegaly).
• Delayed wound healing and frequent abscess formation.
• Oral thrush, chronic mouth ulcers, or recurrent genital yeast infections.

When to See a Doctor

Because infections can progress rapidly in individuals with reduced resistance, seek medical care promptly if you notice any of the following:

• Three or more serious infections within a six‑month period (e.g., pneumonia, sinusitis, or skin abscesses).
• Infections that require hospitalization, intravenous antibiotics, or that do not improve with standard oral therapy.
• Fever lasting longer than three days without an obvious source.
• Unexplained weight loss, night sweats, or persistent fatigue.
• Recurrent oral thrush or genital yeast infections.
• History of HIV exposure, recent chemotherapy, or use of high‑dose steroids.
• Family history of primary immunodeficiency.

Diagnosis

Evaluation focuses on confirming that immunity is compromised and then identifying the underlying cause.

Step‑by‑step approach

1. Detailed medical history – infections frequency, type, severity, vaccination status, medication use, travel, and family history.
2. Physical examination – looks for signs such as lymphadenopathy, splenomegaly, skin lesions, or growth delays in children.
3. Baseline laboratory tests
   • Complete blood count (CBC) with differential – may reveal neutropenia, lymphopenia, or anemia.
   • Quantitative serum immunoglobulins (IgG, IgA, IgM, IgE).
   • Complement levels (C3, C4) if complement deficiency is suspected.
   • HIV serology or viral load.
4. Specialized immune function tests
   • Flow cytometry for B‑cell, T‑cell, and NK‑cell subsets.
   • Neutrophil oxidative burst assay (e.g., DHR test) for chronic granulomatous disease.
   • Specific antibody response to vaccines (e.g., tetanus, pneumococcal).
5. Imaging – chest X‑ray or CT to assess recurrent pulmonary infections; abdominal ultrasound for splenomegaly.
6. Genetic testing – targeted panels or whole‑exome sequencing when a primary immunodeficiency is suspected.

Interpretation of these results should be done by an immunologist or infectious‑disease specialist.

Treatment Options

Management is two‑pronged: treat active infections and address the underlying immune deficit.

Medical Treatments

• Antimicrobial therapy – tailored to the identified pathogen; may require IV antibiotics, antifungals, or antivirals.
• Immunoglobulin replacement (IVIG or subcutaneous IG) for patients with antibody deficiencies such as CVID or X‑linked agammaglobulinemia.
• Antiretroviral therapy (ART) for HIV infection, which restores CD4⁺ counts over time.
• Hematopoietic stem‑cell transplantation (HSCT) – curative for many severe primary immunodeficiencies (e.g., SCID).
• Targeted biologic agents – e.g., granulocyte‑colony stimulating factor (G‑CSF) for neutropenia.
• Prophylactic antibiotics/antifungals – such as trimethoprim‑sulfamethoxazole for Pneumocystis prophylaxis in HIV or patients on high‑dose steroids.

Home and Supportive Care

• Maintain adequate hydration and nutrition; consider supplements (zinc, vitamin D) after checking levels.
• Practice strict hand hygiene and use alcohol‑based hand rubs.
• Avoid crowded places during peak respiratory virus season if you are immunocompromised.
• Keep up‑to‑date with all vaccinations, including seasonal influenza and COVID‑19; live vaccines may be contraindicated—discuss with your doctor.
• Use a temperature‑monitoring chart to track fevers and seek care early if they rise above 38 °C.
• Promptly treat minor wounds; keep them clean and covered to prevent cellulitis.

Prevention Tips

While some causes (e.g., genetics) cannot be changed, many steps can reduce infection risk:

• Vaccination – follow CDC and WHO immunization schedules; consider additional vaccines (pneumococcal, Hib, meningococcal) if advised by an immunologist.
• Nutrition – eat a balanced diet rich in protein, fruits, vegetables, and whole grains. Supplement iron, zinc, selenium, or vitamin D only if a deficiency is documented.
• Hygiene – regular hand washing, avoiding touching the face, and using masks when appropriate.
• Avoid tobacco and limit alcohol — both impair immune function.
• Safe food practices – cook meats thoroughly, wash produce, avoid unpasteurized dairy to prevent food‑borne pathogens.
• Environmental control – limit exposure to mold, dust, and chemicals that irritate respiratory defenses.
• Regular medical follow‑up – especially for chronic conditions (diabetes, kidney disease, HIV) to keep disease control optimal.

Emergency Warning Signs

Key Take‑aways

Resistance to infection reflects the health of your immune system. When it drops, infections become more frequent, severe, or atypical. Early recognition, thorough evaluation, and targeted therapy—often in partnership with immunology specialists—are essential to reduce morbidity. Maintaining good nutrition, vaccinations, hygiene, and chronic‑disease control can help preserve immune defenses.

---

References: Mayo Clinic. “Immunodeficiency.”; CDC. “Vaccines for People with Immunocompromising Conditions.”; NIH. “Primary Immunodeficiency Diseases.”; WHO. “Immunisation Coverage.”; Cleveland Clinic. “Intravenous Immunoglobulin (IVIG).”; Journal of Clinical Immunology, 2022; 42(3): 345‑360.

```